The Use of Real-World Evidence for Decision-Making: Next Steps to Develop HTA Guidance

Public Events YouTube

Can Endpoints from Digital Technology Provide Meaningful Outcomes for HTA? (25/06/2024)

Stakeholder Actions to Generate Better Real-World Evidence for HTA and Payers (26/03/2024)

Real-World Evidence over the Medicine’s Lifecycle to Inform HTA/Payer Decisions (23/11/23, Brussels)

RWE4Decisions Public Webinar | RWE over the lifecycle of ATMPs to meet the HTA (Regulation) Needs

RWE4Decisions Webinar | Beating Cancer with Highly Innovative Technologies - What's the role of RWE?

RWE4Decisions Symposium 2022: Policies & Partnerships

Supporting HTA bodies' and Payers decision-making: Health data initiatives in Germany

RWE4Decisions Public Webinar: National health data initiatives from Finland, Spain and France

RWE4Decisions | Evidence Generation Action Plan for Better Healthcare Systems & Patient Outcomes

The Use of Real-World Evidence for Decision-Making: Next Steps to Develop HTA Guidance

Delivering a Health Data Strategy for the European Reference Networks

Co-Creating RWE Excellence for Decision-Making: Meeting Regulatory and HTA/Payer Needs - Webinar

Realising the Potential of Real World Evidence for Learning Healthcare Systems - 22 September 2020

Health Innovation - the European Health Data Space and Real-World Evidence

Browse

Home
About Us
Steering Group
Stakeholder Actions
Outputs
Events
Contact Us
Privacy Policy

For further information on the RWE4Decisions initiative, please contact secretariat@rwe4decisions.com

@RWE4Decisions

YouTube

LinkedIn

Join our Mailing List

If you wish to be added to our mailing list, please enter your email address below. We will only use your email address in conjunction with our mailing list to send you occasional updates on RWE4Decision’s work. Please read our privacy policy for more details.

FIPRA has facilitated the multi-stakeholder discussions with sponsorship by the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), AstraZeneca, Boehringer Ingelheim, Gilead, Novartis, Pfizer, Roche and Takeda.

About Us
Steering Group
Stakeholder Actions
Outputs
Events
Contact Us

We use cookies to ensure that we give you the best experience on our website. Continuing to use this site assumes you are happy to accept cookies.Accept Privacy policy